Reprint
Management of Venous and Arterial Thrombosis
Edited by
May 2024
282 pages
- ISBN978-3-7258-1179-3 (Hardback)
- ISBN978-3-7258-1180-9 (PDF)
This book is a reprint of the Special Issue Management of Venous and Arterial Thrombosis that was published in
Medicine & Pharmacology
Public Health & Healthcare
Summary
This reprint focuses on research on arterial and venous thromboembolic complications. The authors provide up-to-date information about the pathogenesis, risk stratification, diagnostics and treatment of various forms of thromboembolism including venous thrombosis, pulmonary embolism, cerebral sinus thrombosis, splanchnic thrombosis, ischemic stroke, acute coronary syndrome and pregnancy loss. Additionally, they included the advances of such management in specific populations, such as the patients with endocrine disorders, cancer or COVID-19.
Format
- Hardback
License and Copyright
© 2024 by the authors; CC BY-NC-ND license
Keywords
myocardial infarction; thrombus; thrombophilia; embolism; SARS-CoV-2 infection; COVID-19; coronary artery thrombosis; neutrophil extracellular traps (NETs); risk assessment; pulmonary embolism; thrombolysis; acute mesenteric ischemia; lactate; morbidity; mortality; PCSK9 monoclonal antibodies; inflammation; endothelial dysfunction; haemostasis; thrombosis; coagulation; fibrinolysis; cancer; venous thromboembolism; anticoagulants; recurrence; score; pulmonary embolism; pulmonary embolism response team; PERT; catheter-based therapies; pulmonary embolism; TNF-related apoptosis-inducing ligand; prognosis; risk stratification; thrombophilia; sticky platelet syndrome; hyperaggregability; cerebral venous sinus thrombosis; endovascular therapy; thrombolysis; thrombectomy; intracerebral hemorrhage; anticoagulation; VITT; stroke; CNS; ischaemic; haemorrhagic; biomarker; panel; young adults; children; triage; specificity; sensitivity; prediction values; Venous thromboembolism; quality improvement; VTE prophylaxis; blood coagulation cascade; data mining; heme; hemolysis; knowledge graph; platelet activation; thrombosis; bicuspid aortic valve; aortopathy; classification; diagnosis; treatment; direct oral anticoagulants; tailored medicine; DOAC laboratory monitoring; atrial fibrillation; adverse thrombotic and hemorrhagic events; sticky platelet syndrome; DNA analysis; polymorphisms; antithrombotic treatment; prasugrel; ticagrelor; cangrelor; high on-treatment platelet reactivity; stent thrombosis; acute coronary syndrome; antiplatelet therapy; aspirin; arterial thrombosis; COVID-19; hyperthyroidism; prothrombotic; risk of thrombosis; n/a